(Q34207307)

31 July 2017

1 reference

title

Phenylketonuria: tyrosine beyond the phenylalanine-restricted diet (English)

1 reference

31 July 2017

1 reference

van Spronsen FJ

1

1 reference

31 July 2017

Smit PG

series ordinal

2

1 reference

31 July 2017

Koch R

series ordinal

3

1 reference

31 July 2017

publication date

1 February 2001

1 reference

Journal of Inherited Metabolic Disease

31 July 2017

published in

1 reference

31 July 2017

volume

24

1 reference

31 July 2017

issue

1

1 reference

31 July 2017

page(s)

1-4

1 reference

Valine, isoleucine, and leucine. A new treatment for phenylketonuria

31 July 2017

cites work

1 reference

12 December 2020

Neuropsychology of early-treated phenylketonuria: specific executive function deficits

1 reference

12 December 2020

Cognition and tyrosine supplementation among school-aged children with phenylketonuria

1 reference

12 December 2020

Unsuccessful treatment of phenylketonuria with tyrosine

1 reference

12 December 2020

Neuropsychological deficits in early treated phenylketonuric children.

1 reference

12 December 2020

Genetic failure of fetal amino acid “justification”: A common basis for many forms of metabolic, nutritional, and “nonspecific” mental retardation

1 reference

12 December 2020

Tyrosine supplementation during pregnancy in a woman with classical phenylketonuria. A case report

1 reference

12 December 2020

Historical perspective: tyrosine and maternal phenylketonuria, welcome news

1 reference

12 December 2020

Randomised controlled trial of tyrosine supplementation on neuropsychological performance in phenylketonuria

1 reference

12 December 2020

Tyrosine supplementation for phenylketonuria treatment

1 reference

12 December 2020

Maternal phenylketonuria and hyperphenylalaninemia. An international survey of the outcome of untreated and treated pregnancies

1 reference

12 December 2020

Large neutral amino acids block phenylalanine transport into brain tissue in patients with phenylketonuria

1 reference

12 December 2020

Effect of high-dose tyrosine supplementation on brain function in adults with phenylketonuria

1 reference

12 December 2020

Reduction of cerebrospinal fluid phenylalanine after oral administration of valine, isoleucine, and leucine

1 reference

12 December 2020

Increased Vigilance and Dopamine Synthesis by Large Doses of Tyrosine or Phenylalanine Restriction in Phenylketonuria

1 reference

12 December 2020

Evidence for the importance of dopamine for prefrontal cortex functions early in life

1 reference

12 December 2020

Decreased vigilance and neurotransmitter synthesis after discontinuation of dietary treatment for phenylketonuria in adolescents.

1 reference

12 December 2020

Neurotransmitter positron emission tomographic-studies in adults with phenylketonuria, a pilot study

1 reference

12 December 2020

Effect of L-dopa on pattern visual evoked potentials (P-100) and neuropsychological tests in untreated adult patients with phenylketonuria

1 reference

12 December 2020

The effects of high phenylalanine concentrations on serotinin and catecholamine metabolism in the human brain

1 reference

12 December 2020

Neuropsychological and neuroradiological (MRI) variations during phenylalanine load: protective effect of valine, leucine, and isoleucine supplementation

1 reference

12 December 2020

Large doses of tryptophan and tyrosine as potential therapeutic alternative to dietary phenylalanine restriction in phenylketonuria

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1005689232358

1 reference

Dimensions Publication ID

31 July 2017

1036125105

0 references

1 reference